4,0
24 apr 2025
Dipendente attuale, più di 8 anni
Praga
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Decent pay, good team, nice offices
Svantaggi
As key drug Keytruda approaches end of patent, company is in flux. Cost cutting and pressure increase.